Controlled Substance Agreements for Opioids in a Primary Care Practice

por Philpot, Lindsey M., Ramar, Priya, Elrashidi, Muhamad Y., Mwangi, Raphael, North, Frederick, Ebbert, Jon O.
Publicado 2017

High level MYC amplification in B-cell lymphomas: is it a marker of aggressive disease?

por Pophali, Priyanka A., Marinelli, Lisa M., Ketterling, Rhett P., Meyer, Reid G., McPhail, Ellen D., Kurtin, Paul J., Mwangi, Raphael, Maurer, Matthew J., Habermann, Thomas, King, Rebecca L.
Publicado 2020

P1152: DEPTH OF METABOLIC RESPONSE AT INTERIM PET AND SURVIVAL OUTCOMES AMONG PATIENTS WITH PRIMARY REFRACTORY OR EARLY RELAPSING DIFFUSE LARGE B-CELL LYMPHOMA (DLBCL)

por Bock, Allison, Mwangi, Raphael, Ataei, Fatemeh, Thorpe, Matthew, Maurer, Matthew, Pritchett, Josh, Shreve, Jacob, Paludo, Jonas, Cerhan, James, Khurana, Arushi, Witzig, Thomas, Habermann, Thomas, Wang, Yucai, Nowakowski, Grzegorz S., Young, Jason
Publicado 2023

Patterns of therapy initiation during the first decade for patients with follicular lymphoma who were observed at diagnosis in the rituximab era

por Arushi Khurana, Mwangi, Raphael, Ansell, Stephen M., Habermann, Thomas M., Cerhan, James R., Strouse, Christopher, Link, Brian K., Wang, Yucai, King, Rebecca L., Macon, William R., Villasboas, J. C., Witzig, Thomas E., Maurer, Matthew J., Nowakowski, Grzegorz S.
Publicado 2021

Increasing tissue requirements in lymphoma trials may exclude patients with high-risk disease or worse prognosis

por Desai, Sanjal H., Mwangi, Raphael, Ng, Wern Lynn, King, Rebecca L., Maurer, Matthew J., Cerhan, James R., Feldman, Andrew L., Farooq, Umar, Mou, Eric, Habermann, Thomas M., Thompson, Carrie A., Wang, Yucai, Witzig, Thomas E., Nowakowski, Grzegorz S.
Publicado 2022

Cell of origin is not associated with outcomes of relapsed or refractory diffuse large B cell lymphoma

por Desai, Sanjal H., Mwangi, Raphael, Smith, Alexandra N., Maurer, Matthew J., Farooq, Umar, King, Rebecca L., Cerhan, James R., Feldman, Andrew L., Habermann, Thomas M., Thompson, Carrie A., Wang, Yucai, Ansell, Stephen M., Witzig, Thomas E., Nowakowski, Grzegorz S.
Publicado 2022

Thyroid hormone treatment among pregnant women with subclinical hypothyroidism: US national assessment

por Maraka, Spyridoula, Mwangi, Raphael, McCoy, Rozalina G, Yao, Xiaoxi, Sangaralingham, Lindsey R, Singh Ospina, Naykky M, O’Keeffe, Derek T, De Ycaza, Ana E Espinosa, Rodriguez-Gutierrez, Rene, Coddington, Charles C, Stan, Marius N, Brito, Juan P, Montori, Victor M
Publicado 2017

Clinicopathologic Characteristics, Treatment, and Outcomes of Post-transplant Lymphoproliferative Disorders: A Single-institution Experience Using 2017 WHO Diagnostic Criteria

por King, Rebecca L., Khurana, Arushi, Mwangi, Raphael, Fama, Angelo, Ristow, Kay M., Maurer, Matthew J., Macon, William R., Ansell, Stephen M., Bennani, N. Nora, Kudva, Yogish C., Walker, Randall C., Watt, Kymberly D., Schwab, Thomas R., Kushwaha, Sudhir S., Cerhan, James R., Habermann, Thomas M.
Publicado 2021

PET2 response associated with survival in newly diagnosed diffuse large B-cell lymphoma: results of two independent prospective cohorts

por Desai, Sanjal H., Pederson, Levi, LaPlant, Betsy, Mwangi, Raphael, Maurer, Matthew, Young, Jason R., Macon, William R., King, Rebecca L., Wang, Yucai, Cerhan, James R., Feldman, Andrew, Inwards, David J., Micallef, Ivana, Johnston, Patrick, Porrata, Luis F., Ansell, Stephen M., Habermann, Thomas M., Witzig, Thomas E., Nowakowski, Grzegorz S.
Publicado 2022

Causes of death in low-grade B-cell lymphomas in the rituximab era: a prospective cohort study

por Tun, Aung M., Khurana, Arushi, Mwangi, Raphael, Link, Brian K., Wang, Yucai, Feldman, Andrew L., Thompson, Carrie A., Novak, Anne J., Villasboas, Jose C., Thanarajasingam, Gita, Farooq, Umar, Syrbu, Sergei, Nowakowski, Grzegorz S., Witzig, Thomas E., Ansell, Stephen M., Rimsza, Lisa M., Cerhan, James R., Habermann, Thomas M., Maurer, Matthew J.
Publicado 2022

GM-CSF disruption in CART cells modulates T cell activation and enhances CART cell anti-tumor activity

por Cox, Michelle J., Roman, Claudia Manriquez, Tapper, Erin E., Siegler, Elizabeth L., Chappell, Dale, Durrant, Cameron, Ahmed, Omar, Sinha, Sutapa, Mwangi, Raphael, Scott, Nancy S., Hefazi, Mehrdad, Schick, Kendall J., Horvei, Paulina, Ruff, Michael W., Can, Ismail, Adada, Mohamad, Bezerra, Evandro, Fonkoua, Lionel Aurelien Kankeu, Parikh, Sameer A., Kay, Neil E., Sakemura, Reona, Kenderian, Saad S.
Publicado 2022

Response to COVID-19 Vaccination Post-CAR T Therapy in Patients With Non-Hodgkin Lymphoma and Multiple Myeloma

por Wiedmeier-Nutor, Julia E., Iqbal, Madiha, Rosenthal, Allison C., Bezerra, Evandro D., Garcia-Robledo, Juan Esteban, Bansal, Radhika, Johnston, Patrick B., Hathcock, Matthew, Larsen, Jeremy T., Bergsagel, P. Leif, Wang, Yucai, Reeder, Craig B., Leis, Jose F., Fonseca, Rafael, Palmer, Jeanne M., Gysbers, Brianna J., Mwangi, Raphael, Warsame, Rahma M., Kourelis, Taxiarchis, Hayman, Suzanne R., Dingli, David, Kapoor, Prashant, Kumar, Shaji K., Durani, Urshila, Villasboas, Jose C., Paludo, Jonas, Bennani, N. Nora, Nowakowski, Grzegorz, Ansell, Stephen M., Castro, Januario E, Kharfan-Dabaja, Mohamed A., Lin, Yi, Vergidis, Paschalis, Murthy, Hemant S., Munoz, Javier
Publicado 2023